Despite multiple signaling aberrations providing challenges for efficient therapeutic strategies, recent studies have unveiled unique vulnerabilities of basal-like breast cancers, such as higher levels of PD-L1 expression along with constitutive IFNγ signaling activation13, in line with higher immune-infiltration scores6. This evidence concerns the gene CD274 and breast cancer.